Show simple item record

dc.contributor.authorMurueta-Goyena Larrañaga, Ane
dc.contributor.authorDel Pino Sáez, Rocío
dc.contributor.authorReyero Lobo, Paula
dc.contributor.authorGaldós Iztueta, Marta
dc.contributor.authorArana Larrea, Begoña
dc.contributor.authorLucas Jiménez, Olaia
dc.contributor.authorAcera, Marian
dc.contributor.authorTijero Merino, Beatriz
dc.contributor.authorIbarretxe Bilbao, Naroa
dc.contributor.authorOjeda, Natalia
dc.contributor.authorPena, Javier
dc.contributor.authorCortés Díaz, Jesús María
dc.contributor.authorGómez Esteban, Juan Carlos
dc.contributor.authorGabilondo Cuellar, Iñigo
dc.date.accessioned2019-12-30T09:37:43Z
dc.date.available2019-12-30T09:37:43Z
dc.date.issued2019-05-28
dc.identifier.citationMovement Disorders 34(9) : 1315-1324 (2019)es_ES
dc.identifier.issn0885-3185
dc.identifier.issn1531-8257
dc.identifier.urihttp://hdl.handle.net/10810/37406
dc.description.abstractBackground Retinal optical coherence tomography findings in Lewy body diseases and their implications for visual outcomes remain controversial. We investigated whether region-specific thickness analysis of retinal layers could improve the detection of macular atrophy and unravel its association with visual disability in Parkinson's disease. Methods Patients with idiopathic Parkinson's disease (n = 63), dementia with Lewy bodies (n = 8), and E46K mutation carriers in the alpha-synuclein gene (E46K-SNCA) (n = 4) and 34 controls underwent Spectralis optical coherence tomography macular scans and a comprehensive battery of visual function and cognition tests. We computed mean retinal layer thicknesses of both eyes within 1-, 2-, 3-, and 6-mm diameter macular discs and in concentric parafoveal (1- to 2-mm, 2- to 3-mm, 1- to 3-mm) and perifoveal (3- to 6-mm) rings. Group differences in imaging parameters and their relationship with visual outcomes were analyzed. A multivariate logistic model was developed to predict visual impairment from optical coherence tomography measurements in Parkinson's disease, and cutoff values were determined with receiver operating characteristic analysis. Results When compared with controls, patients with dementia with Lewy bodies had significant thinning of the ganglion cell-inner plexiform layer complex within the central 3-mm disc mainly because of differences in 1- to 3-mm parafoveal thickness. This parameter was strongly correlated in patients, but not in controls, with low contrast visual acuity and visual cognition outcomes (P < .05, False Discovery Rate), achieving 88% of accuracy in predicting visual impairment in Parkinson's disease. Conclusion Our findings support that parafoveal thinning of ganglion cell-inner plexiform complex is a sensitive and clinically relevant imaging biomarker for Lewy body diseases, specifically for Parkinson's disease. (c) 2019 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.es_ES
dc.description.sponsorshipThis study was partially cofunded by the Michael J. Fox Foundation (2014 Rapid Response Innovation Awards; Grant 10189), by the Carlos III Health Institute through Projects PI14/00679 and PI16/00005, and Juan Rodes Grant JR15/00008 (I.G.) (cofunded by the European Regional Development Fund/European Social Fund "Investing in Your Future"), and by the Department of Health of the Basque Government through Project 2016111009es_ES
dc.language.isoenges_ES
dc.publisherWileyes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectdementia with Lewy bodieses_ES
dc.subjectmaculaes_ES
dc.subjectoptical coherence tomographyes_ES
dc.subjectparkinson's diseasees_ES
dc.subjectvisual dysfunctiones_ES
dc.subjectalpha-synucleines_ES
dc.subjectnerve-fiberes_ES
dc.subjectplexiform layeres_ES
dc.subjectganglion-celles_ES
dc.subjectthicknesses_ES
dc.subjectdementiaes_ES
dc.subjectseverityes_ES
dc.subjectelectrophysiologyes_ES
dc.titleParafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseaseses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holderThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.es_ES
dc.rights.holderAtribución-NoComercial-SinDerivadas 3.0 España*
dc.relation.publisherversionhttps://onlinelibrary.wiley.com/doi/full/10.1002/mds.27728es_ES
dc.identifier.doi10.1002/mds.27728
dc.departamentoesBiología celular e histologíaes_ES
dc.departamentoesNeurocienciases_ES
dc.departamentoeuNeurozientziakes_ES
dc.departamentoeuZelulen biologia eta histologiaes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Except where otherwise noted, this item's license is described as This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.